Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5. This indicates the page was updated to a newer site release.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNo additions or deletions were provided for this page, so there are no changes to interpret in context.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page displays a new revision tag, Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a small patch to the page rendering or backend that does not affect the study details.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a small patch to the page's metadata. The visible content and study details remain unchanged.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page's revision indicator was updated from v3.6.0 to v3.6.3, signaling a recent update to the page. This change does not alter the study information displayed.SummaryDifference0.1%

- Check92 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Study Plan header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment', the recruitment status was updated to 'No longer looking for participants', and a site revision tag 'v3.6.0' indicates a recent update.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.